Related references
Note: Only part of the references are listed.Effects of sodium-glucose cotransporter 2 inhibitors on serum uric acid in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis
Xiaodong Hu et al.
DIABETES OBESITY & METABOLISM (2022)
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project
Elisa Russo et al.
JOURNAL OF NEPHROLOGY (2022)
Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial
David Fitchett et al.
ESC HEART FAILURE (2022)
Treating Hyperuricemia: The Last Word Hasn't Been Said Yet
Elisa Russo et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial
David Fitchett et al.
ESC HEART FAILURE (2021)
Uric acid in CKD: has the jury come to the verdict?
Barbara Bonino et al.
JOURNAL OF NEPHROLOGY (2020)
The role of uric acid in inflammasome-mediated kidney injury
Tarcio Teodoro Braga et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
A. Doria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy
Elisa Russo et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes A Systematic Review and Meta-Analysis
Qi Chen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease
Markus Sellmayr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
Sunao Kojima et al.
EUROPEAN HEART JOURNAL (2019)
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study
Daniel M. Jordan et al.
PLOS MEDICINE (2019)
The role of oxidative stress-mediated apoptosis in the pathogenesis of uric acid nephropathy
Lijuan Yang et al.
RENAL FAILURE (2019)
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF
Ulrik M. Mogensen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD
Anand Srivastava et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi et al.
DIABETES CARE (2018)
The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes
Aila J. Ahola et al.
KIDNEY INTERNATIONAL (2017)
Soluble Uric Acid Activates the NLRP3 Inflammasome
Tarcio Teodoro Braga et al.
SCIENTIFIC REPORTS (2017)
The role of hyperuricemia on vascular endothelium dysfunction
Haitao Zhen et al.
BIOMEDICAL REPORTS (2017)
Uric acid in metabolic syndrome: From an innocent bystander to a central player
Mehmet Kanbay et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
Tushar Madaan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
Dipankar Sircar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
Marian Goicoechea et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial
Kenichi Tanaka et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study
Shigemasa Tani et al.
CLINICAL DRUG INVESTIGATION (2015)
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
Bhadran Bose et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: Insights from the I-DEMAND study
F. Viazzi et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Serum Uric Acid Is Associated with Incident Chronic Kidney Disease in Middle-Aged Populations: A Meta-Analysis of 15 Cohort Studies
Ping Zhu et al.
PLOS ONE (2014)
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of End Points in Noninsulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Neeraj Dhaun et al.
HYPERTENSION (2012)
Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial
Yongjun Shi et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Uric Acid-Induced Endothelial Dysfunction Is Associated with Mitochondrial Alterations and Decreased Intracellular ATP Concentrations
Laura Gabriela Sanchez-Lozada et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Yan Miao et al.
HYPERTENSION (2011)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study
Diana I. Jalal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function
Mariano Malaguarnera et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Tomoki Kosugi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Uric acid and incident kidney disease in the community
Daniel E. Weiner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia
Laura G. Sanchez-Lozada et al.
NEPHRON PHYSIOLOGY (2008)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Hyperuricemia induces endothelial dysfunction
UM Khosla et al.
KIDNEY INTERNATIONAL (2005)
Uric acid and the state of the intrarenal renin-angiotensin system in humans
TS Perlstein et al.
KIDNEY INTERNATIONAL (2004)
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2
J Kanellis et al.
HYPERTENSION (2003)
Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity
S Watanabe et al.
HYPERTENSION (2002)
Hyperuricemia induces a primary renal arteriolapathy in rats by a blood pressure-independent mechanism
M Mazzali et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Share Paper
